Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Glioblastoma 18Carcinoma, Non-Small-Cell Lung 6Glioma 5Brain Neoplasms 5Head and Neck Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Astrocytoma 3Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pain 2Lung Neoplasms 2Gliosarcoma 2Central Nervous System Neoplasms 2Bone Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomatitis 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Nervous System Diseases 1Neoplasms by Site 1

Interventions

Injections 24pembrolizumab 13toripalimab 12tislelizumab 9Gemcitabine 7Cisplatin 7Carboplatin 6atezolizumab 5Nivolumab 5Irinotecan 5Pemetrexed 4Oxaliplatin 4Leucovorin 4Fluorouracil 4Docetaxel 4Cetuximab 4trastuzumab deruxtecan 3spartalizumab 3cediranib 3Paclitaxel 3PM 01183 3Capecitabine 3sintilimab 2olaparib 2lenvatinib 2glumetinib 2camrelizumab 2apatinib 2Therapeutics 2Midazolam 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Advanced Solid Tumor × Radiation × Clear all
NCT06182579 2025-09-17

Phase I Study of RiMO-401 With Radiation in Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Terminated
5 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡